Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a ‘black-box’ solution?

Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes

(2016) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

High-resolution mass spectrometry in toxicology: current status and future perspectives

(2016) H. H. Maurer et al.   ARCHIVES OF TOXICOLOGY

Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project

(2016) Olof Beck et al.   CLINICAL TOXICOLOGY

Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project

(2016) Anders Helander et al.   CLINICAL TOXICOLOGY

Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays

(2016) Madeleine Pettersson Bergstrand et al.   Drug Testing and Analysis

Doping control analysis of 46 polar drugs in horse plasma and urine using a ‘dilute-and-shoot’ ultra high performance liquid chromatography-high resolution mass spectrometry approach

(2016) Wai Him Kwok et al.   JOURNAL OF CHROMATOGRAPHY A

Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry

(2016) Christian Görgens et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Rapid screening and determination of 11 new psychoactive substances by direct analysis in real time mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry

(2016) Honggang Nie et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

“Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing

(2015) Christian Görgens et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Evolution of Orbitrap Mass Spectrometry Instrumentation

(2015) Shannon Eliuk et al.   Annual Review of Analytical Chemistry

Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine

(2014) Mira Sundström et al.   Drug Testing and Analysis

Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project

(2014) Anders Helander et al.   FORENSIC SCIENCE INTERNATIONAL

Future applications of high-resolution MS to meet the demands for pain management drug testing

(2014) Bridgit O Crews   Bioanalysis

Methods for urine drug testing using one-step dilution and direct injection in combination with LC–MS/MS and LC–HRMS

(2014) Olof Beck et al.   Bioanalysis

Recent developments in urinalysis of metabolites of new psychoactive substances using LC–MS

(2014) Frank T Peters   Bioanalysis

Multicomponent LC–MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine—Experience from the Swedish population

(2013) Yasir Al-Saffar et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?

(2012) Hans H. Maurer   JOURNAL OF CHROMATOGRAPHY A

Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs

(2011) Charlotte Bell et al.   Drug Testing and Analysis